Bellevue Asset Management »

Karuna Therapeutics Ord shares owned by Bellevue Asset Management

Quarter-by-quarter ownership of Karuna Therapeutics Ord shares owned by Bellevue Asset Management from 13F filings

Historical chart of Bellevue Asset Management investment in Karuna Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Karuna Therapeutics Ord held by Bellevue Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karuna Therapeutics Ord by Bellevue Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.3k 4 316.50

More positions owned by Bellevue Asset Management

Microsoft Corporation (MSFT)
Apple (AAPL)
First Tr Exchng Traded Fd Vi Tcw Opportunis (FIXD)
First Tr Mid Cap Core Alphad Com Shs (FNX)
Capital Group Growth Etf Shs Creation Uni (CGGR)
First Tr Exchange-traded Risng Divd Achiv (RDVY)
Starbucks Corporation (SBUX)
Costco Wholesale Corporation (COST)
Jp Morgan Exchange Traded F Intrnl Res Eqt (JIRE)
Amazon (AMZN)
Vanguard World Fds Inf Tech Etf (VGT)
Jp Morgan Exchange Traded F Equity Premium (JEPI)
First Tr Exchange-traded First Tr Enh New (FTSM)
Jp Morgan Exchange Traded F Nasdaq Eqt Prem (JEPQ)
Abbott Laboratories (ABT)

View all positions for Bellevue Asset Management

Top funds holding Karuna Therapeutics Ord

Vanguard Group
T. Rowe Price Associates
Pentwater Capital Management
Wellington Management Company
UBS Group
Alliancebernstein
Norges Bank Investment Management
Balyasny Asset Management
First Light Asset Management
Citadel Advisors
Boxer Capital
Fiera Capital Corporation
Charles Schwab Investment Management
Alpine Associates Management
Avidity Partners Management

View all funds holding Karuna Therapeutics Ord